Sep 1, 2026 09:09AM
Sep 1, 2026 07:15AM
Sep 1, 2026 04:07AM
Aug 31, 2026 01:05PM
Aug 31, 2026 12:31PM
Aug 31, 2026 10:56AM
Aug 28, 2026 08:30PM FDA approves Takeda's rusfertide for polycythemia vera treatment
Aug 28, 2026 08:30PM
Aug 18, 2026 04:05PM
Aug 10, 2026 04:12AM
Aug 6, 2026 02:34AM
Aug 5, 2026 04:05PM
Aug 4, 2026 04:05PM
Jul 17, 2026 05:06AM Protagonist Therapeutics (PTGX) PT Raised to $165 at Citizens as Icotyde Revenue Ramps
Jul 16, 2026 04:05PM
Jul 7, 2026 06:03AM
Jul 1, 2026 04:05PM
Jul 1, 2026 09:13AM
Jun 16, 2026 04:00PM
May 28, 2026 07:05AM
May 21, 2026 05:32AM Wolfe Research Starts Protagonist Therapeutics (PTGX) at Outperform
May 11, 2026 09:22AM
May 6, 2026 04:28AM
May 5, 2026 05:24PM
May 5, 2026 04:05PM
Apr 28, 2026 09:05AM
Apr 16, 2026 04:05PM
Apr 14, 2026 03:13PM Jefferies stays Buy on Protagonist Therapeutics (PTGX) amid JNJ's bullish tone on Icotyde
Apr 14, 2026 01:03PM
Apr 6, 2026 04:06PM
Mar 28, 2026 10:05AM
Mar 28, 2026 10:05AM
Mar 18, 2026 03:39PM
Mar 18, 2026 12:17PM
Mar 18, 2026 12:14PM Protagonist Therapeutics (PTGX) PT Raised to $121 at Jefferies
Mar 18, 2026 10:28AM
Mar 18, 2026 08:05AM
Mar 18, 2026 08:05AM
Mar 2, 2026 06:47AM
Mar 2, 2026 06:01AM
Feb 26, 2026 04:51AM
Feb 25, 2026 05:15PM CORRECTION: Protagonist Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Feb 25, 2026 04:05PM
Jan 30, 2026 06:47AM
Jan 27, 2026 06:52AM
Jan 5, 2026 09:38AM
Jan 5, 2026 07:03AM
Dec 12, 2025 04:54AM
Dec 8, 2025 02:54AM Protagonist and Takeda report 52-week rusfertide data in polycythemia vera
Nov 20, 2025 04:00AM

444,018 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All